Paula Wittler Joins PetVivo Holdings, Inc. as the Western Business Development Manager
September 07 2022 - 8:00AM
PetVivo Holdings, Inc. (NASDAQ: PETV & PETVW) (the "Company")
an emerging biomedical device company focused on the
commercialization of innovative medical devices and therapeutics
for companion animals and animal athletes is pleased to announce
that Paula Wittler has accepted a position with the Company as its
new Business Development Manager for the Western Region of the
United States.
"We are incredibly excited to add Paula to our
sales and distribution team,” said John Lai, Chief Executive
Officer of PetVivo Holdings, Inc. “The experience Paula brings to
PetVivo is extraordinarily valuable to our efforts in introducing
our innovative product Spryng™ with OsteoCushion™ technology to
veterinarians throughout the United States”
Paula Wittler has more than 25 years of
experience related to management, marketing and distribution of
veterinary products in the United States. She has served in various
roles in product promotion, product distribution, technical sales
and marketing with veterinary companies such as Zoetis Animal
Health (f/k/a Pfizer Animal Health). Paula is a graduate of UC
Santa Barbara. When not working, Paula tries to spend as much time
in the saddle as possible. She competes/shows her Non-Pro Bridle
horse in the National Reined Cow Horse Association, as well as owns
an Open Derby Horse being trained and shown by a professional
trainer.
“Joining PetVivo as a new Business Development
Manager is an incredible opportunity for me to continue my passion,
leverage my industry knowledge, and positively impact the quality
of life for horses and companion animals. I am humbled and honored
to be a part of this valuable team,” said Paula Wittler. “I am
thankful for the opportunity to be able to promote and sell a
veterinary medical device that addresses the affliction (i.e. lost
or damaged cartilage) rather than simply treating the symptoms
(e.g. pain and inflammation). I truly believe Spryng has the
ability to improve the medical outcomes of animals suffering from
lameness and other joint related afflictions, such as
osteoarthritis, thereby enhancing the lives of animals and their
owners.”
For more information about PetVivo Holdings,
Inc. and its innovative product, Spryng, please contact
info1@petvivo.com or visit https://petvivo.com/
and https://sprynghealth.com/.
About PetVivo Holdings,
Inc.
PetVivo Holdings Inc. (NASDAQ: PETV & PETVW)
is an emerging biomedical device company currently focused on the
manufacturing, commercialization and licensing of innovative
medical devices and therapeutics for companion animals. The
Company's strategy is to leverage human therapies for the treatment
of companion animals in a capital and time efficient way. A key
component of this strategy is the accelerated timeline to revenues
for veterinary medical devices, which enter the market much earlier
than more stringently regulated pharmaceuticals and biologics.
PetVivo has a pipeline of seventeen products for
the treatment of animals and people. A portfolio of nineteen
patents protects the Company's biomaterials, products, production
processes and methods of use. The Company’s lead product SPRYNG, a
veterinarian-administered, intraarticular injection for the
treatment of lameness and other joint related afflictions,
including osteoarthritis, in dogs and horses, is currently
available for commercial sale to veterinarians.
CONTACT:
John Lai, CEOPetVivo Holdings, Inc.Email:
info1@petvivo.com(952) 405-6216
Forward-Looking commercial
Statements:
The foregoing material may contain
“forward-looking statements” within the meaning of Section 27A of
the Securities Act of 1933 and Section 21E of the Securities
Exchange Act of 1934, each as amended. Forward-looking statements
include all statements that do not relate solely to historical or
current facts, including without limitation the Company’s proposed
development and commercial timelines, and can be identified by the
use of words such as “may,” “will,” “expect,” “project,”
“estimate,” “anticipate,” “plan,” “believe,” “potential,” “should,”
“continue” or the negative versions of those words or other
comparable words. Forward-looking statements are not guarantees of
future actions or performance. These forward-looking statements,
including the potential listing of the Company’s common stock on
Nasdaq, are based on information currently available the Company
and its current plans or expectations and are subject to a number
of uncertainties and risks that could significantly affect current
plans. Risks concerning the Company’s business are described in
detail in the Company’s Annual Report on Form 10-K for the year
ended March 31, 2022 and other periodic and current reports filed
with the Securities and Exchange Commission. The Company is under
no obligation to, and expressly disclaims any such obligation to,
update or alter its forward-looking statements, whether as a result
of new information, future events or otherwise.
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Mar 2024 to Apr 2024
PetVivo (NASDAQ:PETV)
Historical Stock Chart
From Apr 2023 to Apr 2024